CellScape Corporation to Present New Noninvasive Approach to Prenatal Testing at Cambridge Healthtech Institute's Advances in Prenatal Diagnostics Conference
9/24/2013 9:27:37 AM
NEWARK, Calif., Sept. 24, 2013 (GLOBE NEWSWIRE) -- CellScape Corp, a molecular diagnostics company developing the first noninvasive prenatal genetic test using fetal cells from maternal blood, today announced that Bhairavi Parikh, Ph.D., CellScape's Co-Founder and Chief Technology Officer, will present at the Cambridge Healthtech Institute's Advances in Prenatal Diagnostics Conference taking place in Boston on Tuesday, September 24 at 10:45 AM ET.
Help employers find you! Check out all the jobs and post your resume.
comments powered by